Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: A double-blind, placebo-controlled, randomized clinical trial

Journal of the American College of Nutrition

Volumn 29, Issue 1, 2010, Pages 55-64

  Rondanelli, Mariangela ^a,b   Giacosa, Attilio ^c   Opizzi, Annalisa ^b   Pelucchi, Claudio ^d   La Vecchia, Carlo ^d   Montorfano, Gigliola ^e   Negroni, Manuela ^e   Berra, Bruno ^e   Politi, Pierluigi ^a   Rizzo, Angela Maria ^e  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c Policlinico di Monza   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

AA EPA; Depression; Elderly; N 3 long chain polyunsaturated fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; PLACEBO;

AGED; ARTICLE; BLOATING; BLOOD SAMPLING; BODY COMPOSITION; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ELDERLY CARE; ERUCTATION; ERYTHROCYTE MEMBRANE; FEMALE; GERIATRIC DEPRESSION SCALE; HEADACHE; HEALTH SURVEY; HEMATOLOGICAL PARAMETERS; HUMAN; ITALY; MAJOR CLINICAL STUDY; MENTAL PERFORMANCE; NURSING HOME; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHYSICAL PERFORMANCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CELL MEMBRANE; DEPRESSION; DEPRESSIVE DISORDER; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; ERYTHROCYTES; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; PHOSPHOLIPIDS; QUALITY OF LIFE;

EID: 77956474744     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2010.10719817     Document Type: Article

References (60)

1. Luijendijk HJ, van den Berg JF, Dckker MJ, van Tuijl HR, Otte W, Smit F, Hofman A, Strieker BH, Tiemeier H: Incidence and recurrence of late-life depression. Arch Gen Psychiatry 65:1394-1401, 2008.
2. Lebowitz BD, Pearson JL, Schneider LS, Reynolds CF III, Alexopoulos GS, Bruce ML, Conwell Y, Katz IR, Meyers BS, Morrison MF, Mossey J, Niederehe G, Parmelee P: Diagnosis and treatment of depression in late life: consensus statement update. JAMA 278:1186-1190, 1997.
3. Anderson DN: Treating depression in old age: the reasons to be positive. Age Ageing 30:13-17, 2001.
4. Frasure-Smith N, Lespérance F: Recent evidence linking coronary heart disease and depression. Can J Psychiatry 51:730-737, 2006.
5. Rao R: Cerebrovascular disease and late life depression: an age old association revisited. Int J Geriatr Psychiatry 15:419-133, 2000.
6. Mingo CA, McHvane JM, Baker TA: Explaining the relationship between pain and depressive symptoms in African-American and white women with arthritis. J Natl Med Assoc 100:996-1003, 2008.
7. Olin JT, Schneider LS, Katz IR, Meyers BS, Alexopoulos GS, Breitner JC, Bruce ML, Caine ED, Cummings JL, Devanand DP, Krishnan KR, Lyketsos CG, Lyness JM, Rabins PV, Reynolds CF DI, Rovner BW, Steffens DC, Tariot PN, Lebowitz BD: Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry 10:125-128, 2002.
8. Pearson JL, Conwell Y: Suicide in late life: challenges and opportunities for research. Int Psychogeriatr 7:131-136, 1995.
9. Pearson JL, Brown GK: Suicide prevention in late life: directions for science and practice. Clin Psychol Rev 20:685-705, 2000.
10. Sonnenberg CM, Deeg DJ, Comijs HC, van Tilburg W, Beckman AT: Trends in antidepressant use in the older population: results from the LASA-study over a period of 10 years. J Affect Disord 111:299-305, 2008.
11. Parker G, Gibson NA, Brotchie H, Heruc G, Rees AM, Hadzi-Pavlovic D: Omega-3 fatty acids and mood disorders. Am J Psychiatry 163:969-978, 2006.
12. Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, Lönnqvist J: Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry 161:567-569, 2004.
13. Conklin SM, Manuck SB, Yao JK, Flory JD, Hibbeln JR, Muldoon MF: High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism. Psychosom Med 69:932-934, 2007.
14. Nemets B, Stahl Z, Belmaker RH: Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 159:477-479, 2002.
15. Peet M, Horrobin DF: A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59:913-919, 2002.
16. Lucas M, Asselin G, Mcrette C, Poulin MJ, Dodin S: Ethyl-cicosapcntacnoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial. Am J Clin Nutr 89:641-651, 2009.
17. Delion S, Chalón S, Hérault J, Guilloteau D, Besnard JC, Durand G: Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J Nutr 124:2466-2476, 1994.
18. Delion S, Chalón S, Guilloteau D, Besnard JC, Durand G: Alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J Neurochem 66:1582-1591, 1996.
19. Zimmer L, Hembert S, Durand G, Breton P, Guilloteau D, Besnard JC, Chalón S: Chronic n-3 polyunsaturated fatty acid diet-deficiency acts on dopamine metabolism in the rat frontal cortex: a microdialysis study. Neurosci Lett 240:177-181, 1998.
20. Zimmer L, Durand G, Guilloteau D, Chalón S: n-3 polyunsaturated fatty acid deficiency and dopamine metabolism in the rat frontal cortex. Lipids 34:S251, 1999.
21. Zimmer L, Delion-Vancassel S, Durand G, Guilloteau D, Bodard S, Besnard JC, Chalón S: Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. J Lipid Res 41:32-40, 2000.
22. Zimmer L, Delpal S, Guilloteau D, Aioun J, Durand G, Chalón S: Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex. Neurosci Lett 284:25-28, 2000.
23. Chalón S, Vancassel S, Zimmer L, Guilloteau D, Durand G: Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission. Lipids 36:937-944, 2001.
24. Kodas E, Page G, Zimmer L, Vancassel S, Guilloteau D, Durand G, Chalón S: Neither the density nor function of striatal dopamine transporters were influenced by chronic n-3 polyunsaturated fatty acid deficiency in rodents. Neurosci Lett 321:95-99, 2002.
25. Zimmer L, Vancassel S, Cantagrel S, Breton P, Delamanche S, Guilloteau D, Durand G, Chalón S: The dopamine mesocortico-limbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. Am J Clin Nutr 75:662-667, 2002.
26. Brunello N, Riva M, Rovescalli AC, Galimberti R, Racagni G: Age-related changes in rat serotonergic and adrenergic systems and in receptor responsiveness to subchronic desipramine treatment. Pharmacol Toxicol 63:150-155, 1988.
27. McEntee WJ, Crook TH: Serotonin, memory, and the aging brain. Psychopharmacology 103:143-149, 1991.
28. Hömquist JO: Quality of life: concept and assessment. Scand J Soc Med 18:69-79, 1990.
29. Gallo JJ, Lebowitz BD: The epidemiology of common late-life mental disorders in the community: themes for the new century. Psychiatr Serv 50:1158-1166, 1999.
30. Cohen GD: Depression in late life: an historic account demonstrates the importance of making the diagnosis. Geriatrics 57:38-39, 2002.
31. Folstein MF, Folstein SE, McHugh PR: “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198, 1975.
32. American Psychiatric Association: Mood disorders. In American Psychiatric Association (eds): “Diagnostic and Statistical Manual of Mental Disorders,” 4th ed. Washington, DC: American Psychiatric Association, pp 317-345, 2000.
33. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO: Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37-49, 1983.
34. Sheikh JI, Yesavage JA: Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In Brink TL (ed): “Clinical Gerontology: A Guide to Assessment and Intervention.” New York, NY: The Haworth Press, pp 165-173, 1986.
35. Wancata J, Alexandrowicz R, Marquait B, Weiss M, Friedrich F: The criterion validity of the Geriatric Depression Scale: a systematic review. Acta Psychiatr Scand 114:398-410, 2006.
36. Ware JE, Snow KK, Kosinski M, Gandek B: “SF-36 Health Survey: Manual and Interpretation Guide.” Boston, MA: The Health Institute, 1993.
37. Katz S, Dowrs TD, Cash HR, Grotz RC: Progress in development of the index of ADL. Gerontologist 10:20-30, 1970.
38. Frisancho AR: New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderly. Am J Clin Nutr 40:808-819, 1984.
39. Guigoz Y, Vellas B, Garry PJ: Assessing the nutritional status of the elderly: the Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev 54:S59-S65, 1996.
40. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972.
41. Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497-509, 1957
42. Harris WS, Von Schacky C: The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 39:212-220, 2004.
43. Sims J, Hill K, Davidson S, Gunn J, Huang N: Exploring the feasibility of a community-based strength training program for older people with depressive symptoms and its impact on depressive symptoms. BMC Geriatr 6:18, 2006.
44. Mason P: Fish oils-an update. Pharm J 265:720-723, 2000.
45. Simopoulos AP: The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med 233:674-688, 2008.
46. Petersson H, Basu S, Cederholm T, Risérus U: Serum fatty acid composition and indices of stearoyl-CoA desaturase activity are associated with systemic inflammation: longitudinal analyses in middle-aged men. Br J Nutr 99:1186-1190, 2008.
47. Hrobjartsson A, GOtzsche PC: Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 344:1594-1602, 2001.
48. Walsh BT, Seidman SN, Sysko R, Gould M: Placebo response in studies of major depression: variable, substantial and growing. JAMA 287:1840-1847, 2002.
49. Beckman AT, Copeland JR, Prince MJ: Review of community prevalence of depression in later life. Br J Psychiatry 174:307-311, 1999.
50. Meldon SW, Emerman CL, Schubert DS: Recognition of depression in geriatric ED patients by emergency physicians. Ann Emerg Med 30:442-447, 1997.
51. Raccio-Robak N, McErlcan MA, Fabachcr DA, Milano PM, Verdile VP: Socioeconomic and health status differences between depressed and nondepressed ED elders. Am J Emerg Med 20:71-73, 2002.
52. Luber MP, Meyers BS, Williams-Russo PG, Hollenberg JP, DiDomenico TN, Charlson 5E, Alexopoulos GS: Depression and service utilization in elderly primary care patients. Am J Geriatr Psychiatry 9:169-176, 2001.
53. Krishnan KR, Delong M, Kraemer H, Carney R, Spiegel D, Gordon C, McDonald W, Dew M, Alexopoulos G, Buckwalter K, Cohen PD, Evans D, Kaufmann PG, Olin J, Otey E, Wainscott C: Comorbidity of depression with other medical diseases in the elderly. Biol Psychiatry 52:559-588, 2002.
54. Hibbeln JR: Fish consumption and major depression. Lancet 351:12-13, 1998.
55. Tanskanen A, Hibbeln JR, Tuomilehto J, Uutela A, Haukkala A, Viinamäki H, Lehtonen J, Vartiainen E: Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv 52:529-531, 2001.
56. Edwards R, Peet M, Shay J, Horrobin D: Depletion of docosahexaenoic acid in red blood cell membranes of depressive patients. Biochem Soc Trans 26:S142, 1998.
57. Peet M, Murphy B, Shay J, Horrobin D: Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43:315-319, 1998.
58. Lin PY, Su KP: A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 68:1056-1061, 2007.
59. Austria JA, Richard MN, Chahine MN, Edel AL, Malcomson LJ, Dupasquier CM, Pierce GN: Bioavailability of alpha-linolenic acid in subjects after ingestion of three different forms of flaxseed. J Am Coll Nutr 27:214-221, 2008.
60. Carroll DN, Roth MT: Evidence for the cardioprotective effects of omega-3 fatty acids. Ann Pharmacother 36:1950-1956, 2002.